The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Monday 9 November 2015
The Scottish Medicines Consortium (SMC) has today announced it has accepted an application for first line use of bevacizumab (Avastin) for stage 4 (advanced) ovarian cancer, following a patient consultation, which Target Ovarian Cancer responded to. This means that women with stage 4 ovarian cancer...
Thursday 5 November 2015
On 4 November the All-Party Parliamentary Group on Ovarian Cancer met to find out more about access to drugs across the UK. The meeting was joined by Rachel Cashman, Head of Clinical and Scientific Policy and Strategy at NHS England, was supported by four MPs and a large number of women with...
Friday 11 September 2015
Two of our Research Advocates, Carole and Hilary, attended the NICE scoping meeting for cediranib recently. We asked them to tell us about the experience. "It was for all women - now and in the future - who are fighting for their lives" I was diagnosed with advanced ovarian cancer in January 2012....
Monday 7 September 2015
Today, the Scottish Medicines Consortium (SMC) has announced the results of its recent review of cancer drugs, and has accepted bevacizumab (Avastin) for use in patients who have platinum resistant recurrent ovarian cancer and have received no more than two rounds of chemotherapy. This means that...